SG11201803022TA - Compositions comprising fatty acids and their use - Google Patents
Compositions comprising fatty acids and their useInfo
- Publication number
- SG11201803022TA SG11201803022TA SG11201803022TA SG11201803022TA SG11201803022TA SG 11201803022T A SG11201803022T A SG 11201803022TA SG 11201803022T A SG11201803022T A SG 11201803022TA SG 11201803022T A SG11201803022T A SG 11201803022TA SG 11201803022T A SG11201803022T A SG 11201803022TA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- fatty acids
- fatty
- acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662315152P | 2016-03-30 | 2016-03-30 | |
| US201662315142P | 2016-03-30 | 2016-03-30 | |
| US201662315134P | 2016-03-30 | 2016-03-30 | |
| US201662315158P | 2016-03-30 | 2016-03-30 | |
| US201662315163P | 2016-03-30 | 2016-03-30 | |
| US201662328094P | 2016-04-27 | 2016-04-27 | |
| PCT/EP2016/080786 WO2017167415A1 (en) | 2016-03-30 | 2016-12-13 | Compositions comprising fatty acids and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201803022TA true SG11201803022TA (en) | 2018-05-30 |
Family
ID=57614346
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201803022TA SG11201803022TA (en) | 2016-03-30 | 2016-12-13 | Compositions comprising fatty acids and their use |
| SG11201806545WA SG11201806545WA (en) | 2016-03-30 | 2017-03-30 | Compositions comprising fatty acids and their use |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201806545WA SG11201806545WA (en) | 2016-03-30 | 2017-03-30 | Compositions comprising fatty acids and their use |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP3984532A3 (en) |
| CN (2) | CN108495627A (en) |
| BR (2) | BR112018011412A2 (en) |
| CA (2) | CA3003651A1 (en) |
| MX (3) | MX2018008520A (en) |
| PH (2) | PH12018501027A1 (en) |
| SG (2) | SG11201803022TA (en) |
| WO (2) | WO2017167415A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109714975A (en) * | 2018-09-13 | 2019-05-03 | 北京诺爱真原生物科技有限公司 | One kind is used for after congenital heart disease operation and non-cardiac surgery and other Intensive Care Therapy infant nutrition formulations and its application method |
| CN109805390A (en) * | 2019-02-27 | 2019-05-28 | 云南大学 | A kind of calcium nervonate, nervonic acid zinc and vitamin K2Compound composition soft capsule |
| CN110946099A (en) * | 2019-12-13 | 2020-04-03 | 宁波大学 | Method for improving breeding yield of bivalve offspring seeds |
| CN113508840A (en) * | 2020-04-09 | 2021-10-19 | 北京三元食品股份有限公司 | Application of milk fat globule membrane in preparing milk powder for pregnant women |
| CN114544821B (en) * | 2020-11-24 | 2023-10-24 | 重庆医科大学 | Application of reagent for detecting phosphatidylethanolamine (36:4) in blood plasma in preparation of depression detection kit |
| WO2024038010A1 (en) | 2022-08-18 | 2024-02-22 | Société des Produits Nestlé S.A. | Kit to promote developmental myelination |
| CN116008438B (en) * | 2023-02-07 | 2023-06-06 | 北京三元食品股份有限公司 | Marker group for evaluating fine action development condition of infants and application |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0322589B1 (en) | 1987-12-23 | 1993-01-20 | Societe Des Produits Nestle S.A. | Process for the preparation of a lactoserum protein hydrolysate and a hypoallergenic food |
| GB9416846D0 (en) * | 1994-08-19 | 1994-10-12 | Croda Int Plc | Lipid supplementation |
| EP0880902A1 (en) | 1997-05-27 | 1998-12-02 | Nestlé Produkte AG | Process for treating a raw whey material |
| WO1999063943A2 (en) * | 1998-06-12 | 1999-12-16 | Craig Anthony Cooney | Nutritional methyl supplements change epigenetics, dna methylation, phenotype, and appearance of mammalian offspring |
| WO2001011990A1 (en) | 1999-04-29 | 2001-02-22 | Societe Des Produits Nestle S.A. | Composition for an infant formula having a low threonine content |
| AU2002323409A1 (en) * | 2001-08-24 | 2003-03-10 | Martek Biosciences Boulder Corporation | Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum |
| WO2006099233A2 (en) * | 2005-03-10 | 2006-09-21 | Sciele Pharma, Inc. | Compositions and methods for the treatment of osteoporosis and inflammatory joint disease |
| RU2480474C2 (en) * | 2005-04-28 | 2013-04-27 | Энзимотек Лтд. | Mixtures of polar lipids, production and use thereof |
| HUE031206T2 (en) * | 2005-05-23 | 2017-06-28 | Massachusetts Inst Technology | Compositions containing pufa and methods of use thereof |
| KR101430214B1 (en) * | 2006-12-28 | 2014-08-18 | 산토리 홀딩스 가부시키가이샤 | Nerve regeneration agent |
| EP2110027A1 (en) * | 2008-04-01 | 2009-10-21 | Nestec S.A. | Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation |
| EP2454948A1 (en) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
-
2016
- 2016-12-13 MX MX2018008520A patent/MX2018008520A/en unknown
- 2016-12-13 CA CA3003651A patent/CA3003651A1/en not_active Abandoned
- 2016-12-13 SG SG11201803022TA patent/SG11201803022TA/en unknown
- 2016-12-13 WO PCT/EP2016/080786 patent/WO2017167415A1/en active Application Filing
- 2016-12-13 CN CN201680072969.7A patent/CN108495627A/en active Pending
- 2016-12-13 BR BR112018011412A patent/BR112018011412A2/en not_active IP Right Cessation
-
2017
- 2017-03-30 SG SG11201806545WA patent/SG11201806545WA/en unknown
- 2017-03-30 CN CN201780016207.XA patent/CN108778265A/en active Pending
- 2017-03-30 BR BR112018067999A patent/BR112018067999A2/en not_active Application Discontinuation
- 2017-03-30 EP EP21202004.4A patent/EP3984532A3/en active Pending
- 2017-03-30 WO PCT/EP2017/057576 patent/WO2017167899A1/en active Application Filing
- 2017-03-30 MX MX2018011336A patent/MX2018011336A/en unknown
- 2017-03-30 EP EP17714731.1A patent/EP3435997A1/en not_active Withdrawn
- 2017-03-30 CA CA3015028A patent/CA3015028A1/en active Pending
-
2018
- 2018-05-15 PH PH12018501027A patent/PH12018501027A1/en unknown
- 2018-08-28 PH PH12018550141A patent/PH12018550141A1/en unknown
- 2018-09-18 MX MX2022014683A patent/MX2022014683A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN108778265A (en) | 2018-11-09 |
| SG11201806545WA (en) | 2018-10-30 |
| BR112018067999A2 (en) | 2019-01-15 |
| BR112018011412A2 (en) | 2018-12-04 |
| EP3984532A2 (en) | 2022-04-20 |
| EP3435997A1 (en) | 2019-02-06 |
| MX2022014683A (en) | 2023-01-11 |
| PH12018550141A1 (en) | 2019-03-11 |
| PH12018501027A1 (en) | 2019-01-28 |
| CN108495627A (en) | 2018-09-04 |
| MX2018008520A (en) | 2018-08-16 |
| CA3003651A1 (en) | 2017-10-05 |
| CA3015028A1 (en) | 2017-10-05 |
| EP3984532A3 (en) | 2022-09-21 |
| MX2018011336A (en) | 2019-01-31 |
| WO2017167899A1 (en) | 2017-10-05 |
| WO2017167415A1 (en) | 2017-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL263828A (en) | Triglyceride otic formulations and uses thereof | |
| ZA201704977B (en) | Use of short chain fatty acids in cancer prevention | |
| PT3509638T (en) | Cannabidiolic acid esters compositions and uses thereof | |
| IL271275A (en) | Compositions comprising curons and uses thereof | |
| HK1256040A1 (en) | Compositions containing tannic acids and uses thereof | |
| SG11201803022TA (en) | Compositions comprising fatty acids and their use | |
| ZA201700275B (en) | Cleaning compositions containing high fatty acids | |
| SG11201608217PA (en) | Fatty acid composition and use thereof | |
| ZA202104969B (en) | Compositions comprising 15-hepe and methods of using the same | |
| PL3359632T3 (en) | Compositions comprising sugar amine and fatty acid | |
| IL280690A (en) | Pharmaceutical compositions comprising dgla and use of same | |
| IL262045B (en) | Uv-protective compositions and their use | |
| IL271961A (en) | Compositions comprising thymoquinone and omega-3 fatty acids | |
| HK1244218A1 (en) | Millicapsule formulations comprising polyunsaturated free fatty acids | |
| ZA201702385B (en) | Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states | |
| IL254897A0 (en) | Compositions comprising carotenoids and use thereof | |
| IL290166A (en) | Collagen 7 compositions and use thereof | |
| AP2016009489A0 (en) | Oligonucleotide compositions and methods of making the same | |
| HK1247136A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
| SG11201803027PA (en) | Compositions comprising phospholipid and their use | |
| SG11201803026RA (en) | Compositions comprising choline and their use | |
| HK1251892A1 (en) | Inulin-based combination and use thereof as substitute of fats in food compositions and formulations | |
| HK1249896A1 (en) | Novel triglyceride and use thereof | |
| SG11201803025VA (en) | Compositions comprising vitamins and their use | |
| PL3020794T3 (en) | Detergent composition and use of the same |